SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

Kaleah Balcomb, Caitlin Johnston, Tomas Kavanagh, Glenda M Halliday, Thomas Wisniewski, Margaret Sunde, Eleanor Drummond · 2025

Read SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation by Kaleah Balcomb, Caitlin Johnston, Tomas Kavanagh, Glenda M Halliday, Thomas Wisniewski, Margaret Sunde, Eleanor Drummond (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709629.txt.

Description

Kaleah Balcomb and co-authors investigate a protein that shows up early in Alzheimer's disease. SMOC1 rises in spinal fluid decades before symptoms, yet its job in the brain was unknown. In tissue from seventy four donors, the protein sat inside a large share of amyloid plaques at every disease stage, and its levels tracked total plaque load.

It also touched some tau tangles, more faintly. Lab tests confirmed a direct bond with amyloid. Added to growing amyloid, SMOC1 slowed clumping in a dose dependent way and changed the fibers' shape. The authors suggest the protein may be the brain's attempt to brake plaque growth.

Catalog record

CREATORKaleah Balcomb, Caitlin Johnston, Tomas Kavanagh, Glenda M Halliday, Thomas Wisniewski, Margaret Sunde, Eleanor Drummond
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11709629

Browse the full library · About the Tower of Babel